학술논문
Assessing the selective therapeutic efficacy of superparamagnetic erlotinib nanoparticles in lung cancer by using quantitative magnetic resonance imaging and a nuclear factor kappa-B reporter gene system
Document Type
Article
Author
Source
In Nanomedicine: Nanotechnology, Biology, and Medicine April 2018 14(3):1019-1031
Subject
Language
ISSN
1549-9634